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ABSTRACT OF THE THESIS 
HEART VALVE TISSUE ENGINEERING: A STUDY OF TIME VARYING EFFECTS 
AND SAMPLE GEOMETRY 
by 
Manuel Salinas 
Florida International University, 2011 
Miami, Florida 
Professor Sharan Ramaswamy, Major Professor 
In heart valve tissue engineering (HVTE), it is well established that mechanical 
stimuli improve tissue formation and cell growth. Previous experiments have shown that 
combined flexure and flow increases tissue formation in PLA/PGA scaffolds seeded with 
bone marrow derived stem cells (BMSCs). In addition, computational fluid dynamic 
(CFD) studies have shown that sample bending significantly affects the flow physics. The 
intend of this study was to observe and compare the flow physics between steady state 
and pulsatile cases through computational modeling and in-vitro experiments. A u-shaped 
custom made bioreactor capable of producing flow stretch and flexure was used. CFD 
simulations were performed through Ansys CFX (Ansys, Pittsburgh, PA) for both steady 
and pulsatile flow. The results have shown that OSS can be maximized by inducing 
pulsatile flow over straight scaffolds. Evidence suggests that OSS promotes BMSCs 
tissue formation. 
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1 INTRODUCTION 
Heart valve disease is a major health care concern around the world. It is 
estimated that over 290,000 replacements occur annually, and it is expected to triple in 
the next four decades [1].  Native heart valves (NHVs) are multilayered highly adaptable 
and highly regulated structures. NHVs open and close nearly three billion times in an 
average lifespan and their motion depend on the mechanical and hemodynamic forces 
[2]. Healthy pulmonary heart valves (PHVs) assure one-way blood flow from the right 
ventricle into the pulmonary artery with minimum regurgitation and negligible 
obstruction during systole. During diastole, the PHV closes when the pulmonary artery 
pressure exceeds the ventricular pressure. The closing of the PHVs is aided by flow 
vortices behind the cusps on the arterial side [2].  Native PHVs are subjected to complex 
time-varying stresses due to combinations of flow, stretch and flexure (FSF).  They are 
tightly regulated with continuous tissue remodeling activity capable of adapting to 
different hemodynamic loads [3]. 
 Prosthetic heart valves have shown to provide sufficient functionality; however, 
mechanical heart valves (MHVs) are prone to hemolysis and possible platelet activation 
due to abnormal hemodynamics [4]. On the other hand, biological heart valves (BHVs) 
can fail due to calcification and immune rejection [3,5]. MHVs are widely used among 
pediatric patients due to the risk of BHV calcification resulting from elevated calcium 
concentration found in children [6]. However with MHVs, several revision surgeries are 
necessary to account for the growth of the child. In addition, immune rejection is still a 
problem. Ultimately, prosthetic heart valves do not address tissue adaptation, which is 
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sorely needed among pediatric patients suffering from severe congenital valve 
disease/abnormalities.  
The objectives of this proposal are to study the effects of two parameters that 
could potentially augment in vitro engineered heart valve tissue formation. These 
parameters are linked to the general process of mechanical conditioning which is thought 
to be important in optimizing tissue formation [7,8].  Specifically, this work examined the 
effects of i) sample geometry and ii) pulsatility on fluid-induced stress states and 
subsequent implications that may have on engineered tissue formation, which are 
addressed in the following specific aims.  
2 SPECIFIC AIMS 
Aim 1: Understand the role of specimen geometry in the context of heart valve 
tissue engineering studies. 
Changes in specimen geometry results in spatially varying flow physics. The 
intention is to observe the flow physics that occurs during sample flexure. In order to 
do this, computational fluid dynamics (CFD) simulations were performed as described 
in the methods section. 
Aim 2: Understand the role of pulsatility in the context of heart valve tissue 
engineering studies. 
Pulsatility introduces frequency, waveform, and oscillatory effects. These time 
varying effects that may be important in the development of tissue engineered heart 
valve (TEHV) constructs.  
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Aim 3: Co-relate the role of steady and pulsatile flow-induced stress states to 
engineered tissue formation, specifically collagen and glycosaminoglycan (GAGs) 
production by bone marrow derived stem cells (BMSCs). 
Spatial  and  time  varying  stress  effects  may  improve  tissue  formation  in TEHV 
constructs seeded with BMSCs. Recent studies in heart valve tissue engineering have 
used BMSCs because they are less invasive than other cell sources such as endothelial 
cells (ECs) or smooth muscle cells (SMCs). Comparison of these simulations 
with experimental data was performed. 
3 LITERATURE REVIEW 
3.1 Heart Valve Disease 
Heart Valve disease (HVD) is any of the conditions in which the functioning of 
one or more of the native heart valves (NHVs) is affected. HVD can be caused by 
immune reactions, trauma, genetic and congenital factors as well as environmental 
factors such as diet, smoking habits, and sedentary life. It could affect any of the four 
valves such as the pulmonary ones [9-13]. There are four valves in the heart and they 
open and close in a synchronized manner permitting the blood to travel unidirectionally.  
The atrio-ventricular (A-V) valves (mitral and tricuspid) open when the pressure in the 
atrium exceeds the pressure in the ventricles and allows blood to flow inside the latter. In 
the same manner, when the pressure in the ventricles exceeds that of the atrium in the A-
V valves close. Subsequently, as ventricles contract, the pulmonary and aortic valves 
open allowing blood to flow towards the lungs and aortic artery respectively.  
 Valve stenosis occurs when the valves become stiff or fuse together. This 
decreases the cross sectional area for blood to flow normally thereby affecting the 
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hemodynamics. Another form of HVD is valve regurgitation. In this case, valves do not 
close properly and cause blood to flow back to the heart. As a consequence, blood flow to 
the body can be significantly diminished, therefore making the heart work harder [14,15].   
Pulmonary valves are responsible for allowing blood flow from the heart to the 
lungs for carbon dioxide and oxygen exchange.  When the valve has undergone sufficient 
damage, it needs to be replaced by commercially available prosthetic heart valves. There 
are approximately 15000 pulmonary heart valve replacements each year [16]. In 1995, it 
was shown that it is possible to substitute single native pulmonary leaflets with tissue 
engineered leaflet constructs [17] in lambs. Other studies have reported using trileaflet 
constructs for grafting in sheep and it showed to last for up to 8 months before implant 
failure [17].  
3.2 Heart Valve prosthetics 
Prosthetic heart valves can be classified as either mechanical or bio-prosthetic. 
Mechanical heart valves (MHVs) are typically constructed out of a high strength material 
such as titanium or pyrolytic carbon. MHVs initial designs include the ball and cage, 
tilting disk, and the bileaflet versions. One of the bileaflet designs the St. Jude Medical 
MHV, is the most widely used type of mechanical implant because of superior 
hemodynamics over the other two designs due to lower transvalvular pressure drop 
[6,18,19]. MHVs offer durability and reliability, but they have problems such as 
hemolysis and possible platelet activation due to abnormal hemodynamics [13,20,21]. 
MHVs are recommended for use in adults, but they are contraindicated for children 
because they do not account for somatic growth [14,22].  
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Bio-prosthetic valves (BPVs) are made of native valves explanted from animals 
or cadavers that have undergone proper standards of handling and processing in order to 
be used as human implants [15,23].  For xenografts, swines are the number one choice, 
but it can also be explanted from bovines [13,15].  Some of the problems that accompany 
xenografts or homograft valve implants are calcification and immune rejection which will 
lead to implant failure [24-27].  
 
Figure 1. Mechanical and Biological Heart valves. 
Heart valve tissue engineering aims at the development of an in-vitro implant with 
similar mechanical properties and anatomy as native valves. Moreover, a primary goal of 
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this approach is to promote engineered tissue remodeling and growth [8]. However, no 
long term/ perpetual reliable engineered valve has been obtained thus far due to the 
complexity in mimicking the environments that native valves are exposed to [1,28,29].  
 
 
 
Figure 2. Tissue Engineering Approach 
3.3 Computational Fluid Dynamic in Heart Valves 
Through computational fluid dynamic (CFD) simulations, it has been shown that 
the flow physics acting on native heart valves can be replicated in rectangular 
scaffolds[7]  Ramaswamy et al.[8] designed a custom made bioreactor able to induce 
flow, flexure and stress. The device was capable of housing up to twelve sample 
specimens. The design consisted of four u-tube shape pipe-like chambers of 13 mm 
diameters. Each chamber is capable of housing up to three samples. It was shown that the 
Sheep    Autologous cells (i.e. BMSCs) Cell expansion
Mechanical conditioning 
Conditioned implant Cell seeding 
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device was able to reproduce physiologically valid shear stress (5-6 dynes/cm2) [8] while 
keeping laminar flow and low viscosity (1.27 centipoise).  
 
Figure 3. Computational fluid dynamic simulations on native heart valve (a) 
and rectangular (b) Geometries [7].  
 
3.4 Cell sources for HVTE 
Heart valve tissue engineering studies have been conducted using a variety of cell 
sources [30-33]. Some studies have focused on endothelial (ECs) and smooth muscle 
cells (SMCs).  ECs and SMCs can be obtained primarily from vessels such as arteries. 
However, this is considered to be an invasive form of obtaining cells because vascular 
tissue is compromised and destroyed when extracting these two types of cells [31,34]. 
Nonetheless, these two cell sources have shown to promote tissue formation in studies 
pertaining to engineered heart valves.  Human periodontal ligament derived stem cells 
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(PDLSCs) [35] are another HVTE cell source.  These cells are obtained mainly from 
wisdom teeth surgically extracted and can potentially adopt heart valve phenotypes. More 
recently, HVTE studies have used bone marrow derived mesenchymal stem cells 
(BMSCs) [32,33,36,37].  BMSCs are a practical source autologous progenitor cells 
because they can be obtained in large numbers in a minimally invasive manner [7,38].  
3.5 Scaffolds 
A fundamental aspect in tissue engineering is the use of scaffolds that mimic the 
mechanical and homeostatic conditions of NHVs. It is of utmost importance for cell and 
tissue development to have a suitable porous interface where colonizing cells can attach, 
replicate and produce ECM. Ideally, scaffold degradation rates should match the rate of 
mechanically resilient tissue formation [39]. HVTE studies have used polymeric and 
biological scaffolds. Polylactic acids (PLA), polyglycolic acid (PGA) have been used as 
artificial scaffold materials because of their biocompatibility and biodegradability 
[33,40,41]. These scaffolds can be easily constructed and therefore they can be obtained 
in an efficient manner [40]. However, the disadvantage is that these scaffolds do not 
match the mechanical properties of NHVs and simultaneously offer anatomically shape 
retention [33,40,41].   
Researchers have also investigated the use of decellularized biological scaffolds 
obtained from animal native valves [42]. One of the advantages of using these xeno-
constructs is the conservation of the native heart valve architecture and ECM mechanical 
properties [1,43]. On the other hand, there are still unsolved compatibility issues. This is 
due primarily to the multi-factor interaction between cell sources such as BMSCs and 
decellularized extracellular tissue components such as collagen and other proteins [1,3].  
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3.6 Mechanical Conditioning 
It is well documented that mechanical conditioning plays a role in the in-vitro 
development of vascular tissue [7,44,45]. Basic bioreactors provided dynamic 
conditioning in the form of fluid flow. These devices include compliance and ventricular 
chambers, pneumatic or peristaltic pumps, and sensors. They also use computers with 
specialized software for its monitoring. In some of these devices, pressure wave forms, 
velocities, and shear stress can be adjusted.  
Sodian et al.[16] used a pulsatile bioreactor capable of inducing pulsatile flow and 
pressure. It was used to house tri-leaflet shaped polyhydroxyalkanoate (PHA) scaffolds 
seeded with vascular cells extracted from an ovine carotid artery. Histology showed a 
significant increase in cell proliferation and there was extracellular matrix (ECM) 
deposition in the fluid induced samples when compared to the static (no flow) samples. 
Moreover, cells were aligned in the direction of the flow. Additionally, there was 
presence of collagen and glycosaminoglycans (GAGs). However, there was no evidence 
of elastin production.  It was not clear if the increase in tissue formation was caused by 
the increase number of cells or the pulsatility of the fluid. Evidence regarding phenotype 
changes was not reported.  
Hoerstrup et al.[46] used a pulse duplicator bioreactor on tri-leaflet shaped 
scaffolds made of polyglycolic acid (PGA) and an outer coat of poly-4-hydroxybutyrate 
(P4HB). The constructs were seeded initially with ovine myofibroblasts with subsequent 
seeding of endothelial cells (ECs). Subsequently, the construct was implanted in lambs. 
Blood regurgitation due to inappropriate joining of the leaflets was observed soon after 
in-vivo grafting. 
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Zeltinger et al. [47] used a bioreactor composed of a pneumatic pump used for 
inducing flow on a decellularized aortic valve from a porcine. Neonatal fibroblasts from 
humans were added to the flowing media and it continued to recirculate for 24 hours. The 
study demonstrated that decellularized scaffolds could be populated by colonizing cells. 
However, the construct failed due to valve stenosis, specifically by thickening of the 
cusps soon after implantation.  
Sutherland et al. [29] developed a TEHV seeded with carotid artery-derived 
vascular smooth muscle cells (SMCs) and endothelial cells (ECs). The construct was 
implanted in sheep for up to 20 weeks. Cell differentiation towards a heart valve 
phenotype was observed after post-surgical examination. 
Stickler, et al. [39] developed a device capable of cyclic stretch and implanted it 
on the peritoneal cavities in eight sheep. The implant was designed such that cells 
migrate to the scaffold. The results compared tissue samples cultured under static 
conditions versus cyclic stretching.  It was determined that there was significantly more 
tissue formation in samples exposed to cyclic stretching, specifically that the mechanical 
properties of the tissue were enhanced by a factor of two.  
Lichtenberg et al. [48] used a simple pulsatile bioreactor in order to 
mechanically stimulate a decellularized ovine pulmonary valve seeded with ECs. After 
ECs colonization of the scaffold, a continuous layered architecture was seen. Next, the 
graft was implanted in an ovine, and it performed satisfactorily at the initial stage. 
However, subsequent studies revealed onset of thrombosis and hyperplasia. 
Ceborati et al. [49] collaborated with the Haverich’s group [48] and conditioned 
two decellularized human pulmonary valves seeded with endothelial progenitor cells 
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(EPCs). The grafts were implanted in two pediatric patients. Presently, the two patients 
have been observed to be in good health. Furthermore, the annulus of the graft has shown 
to have grown with the patient.  
Despite the promising results mentioned above, there remain many uncertainties 
when looking at the future of TEHVs. It is well known that stem cells respond to 
chemical and mechanical cues, and that they phenotypic transformation can be guided. 
Mechanical stimulation has also shown to regulate the process of tissue formation. What 
it is not clear yet, is what specific flow physics is causing cells to produce more matrix 
and to differentiate viable progenitor cell types towards the heart valve lineage.  
Custom bioreactors for HVTE studies are laboratory tissue-culture devices that 
can provide a controllable, mechanically active environment that can be used to study and 
potentially improve engineered tissue structure, properties, and integration.  In some of 
these devices the individual or combined effects of flow, stretch, and flexure (FSF) 
stresses can be replicated and studied [38] In 2003, Engelmayr et al.[50]  constructed a 
bioreactor designed to provide engineered tissue constructs with flexural stress 
conditioning. The biopolymeric scaffold was seeded with smooth muscle cells (SMCs). 
The results showed that there was a decrease in the flexural strength of the acellular 
scaffolds with increasing bending cycles. However, when the scaffold was seeded with 
SMCs, the flexural stresses augmented engineered tissue formation.  
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Figure 4. Custom made mechanical conditioning bioreactor for HVTE studies [38]. 
Modes: Flow, stretch, flexure. 
Hildebrand et al.[51] developed a sophisticated bioreactor with a monitoring 
system capable of introducing controlled pressure and waveforms independently.  It used 
a predictive control algorithm that could automatically modulate stroke volume, pump 
rate, systolic and diastolic pressures. The device could incorporate a wide range of 
pulsatile waveforms. Thus, it was able to condition grafts with physiologic and non-
physiologic flow conditions. 
More recently, HVTE studies have used bone marrow derived mesenchymal stem 
cells (BMSCs).  BMSCs are a practical source autologous progenitor cells because they 
can be obtained in large numbers in a minimally invasive manner [7,45,52,53]. 
Engelmayr, et al. [45] showed after 3 weeks of culture that, there was a significantly 
higher amount of engineered tissue formation derived from BSMC-seeded scaffolds 
under combined steady flow and flexure states, in comparison to steady flow or flexure 
alone and to static controls. This finding suggested that cyclic flexure creates specific 
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flow environments in steady flow states that caused the cells to produce more ECM.  
Studies elsewhere have also provided  evidence of flow vortices on the leaflets of native 
valves (aortic side) that seem to provide the physiological benefit of more complete valve 
closure[54,55].  More recently these vortices can be recapitulated in rectangular scaffolds 
that have a bent configuration [7,45] and have been shown to be analogous to vortices 
observed in tri-leaflet heart valves.  
Ramaswamy et al. [7,45] had previously proposed the hypothesis that  oscillatory 
shear stress (OSS) caused by time-varying flow environments, triggered by bending 
geometries, play a critical role in engineered tissue formation derived from BMSCs. 
There is strong evidence to support this hypothesis in other tissue engineering 
applications such as bone. Specifically, OSS has been shown to influence BMSCs 
proliferation and upregulate transcription factors responsible for phenotypic regulation 
[52,56-59]. In particular, Li et al. [53] reported that OSS caused triggering of intracellular 
calcium mobilization in BMSCs and regulation of osteogenic gene expression.  These 
findings translate to HVTE studies using BMSCs and may potentially augment 
engineered tissue formation rates and supporting the heart valve phenotype.  
It was noted that from observing native heart valve dynamics that from a 
biomimetic standpoint, OSS can be created by means of pulsatility or by cyclic specimen 
geometry changes. However, quantification of the individual or combined effects of these 
variables to maximize OSS environments in vitro is to date, not known. Accordingly, this 
study, examined and quantified the role that i) physiologically relevant scales of 
pulsatility and ii) changes in geometry as a function of specimen flexure, have in creating 
OSS conditions for dynamic culture of tissues. This work will allow for the study of 
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valve like configurations and flow environments and the subsequent comparison of the 
surrounding 3-D flow physics under steady and pulsatile conditions. This will permit the 
identification of specific fluid environments that may play a role in engineered heart 
valve tissue formation.  
4 METHODS 
4.1 Methodology for aim 1 and 2 
4.1.1 Initial Geometry and meshing for all simulations/fluid properties 
        Previous efforts have focused on the development of a u-shaped bioreactor capable 
of inducing flow, flexure and tension on rectangular scaffolds (Fig. 5A) [8].  The fluid 
domain of the u-shape bioreactor was constructed (Fig. 1D) through Ansys™ 
commercial software (Ansys Inc, Canonsburg, PA). The mesh was constructed with 
tetrahedral elements (Fig. 6A) Physical properties for bioreactor media were used with 
density = 1.01 g cm3 and dynamic Viscosity = 1.27 centipoise. Simulations were run in 
a Hewlett Packard™ work station with  intel(R)  Xeon(R) CPU, x5550@ 2.67GHz 
(2processors) with 16.0 GB installed memory and 64-bit windows 7 operating system.  
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Figure 5. (A) Peristaltic pump used to induce flow through the FSF bioreactor. 
(B) FSF bioreactor set up. (C) Single FSF bioreactor chamber. (D) Bioreactor 
fluid domain showing the position of the three rectangular specimens. 
 
 
Figure 6. (A) Tetrahedral mesh with 3.1x106 elements and 5.5x105 nodes. (B) 
Close up of the mesh near the sample region. (C) Sample showing inner and outer 
wall and the specimen straight, semi-bent, and fully-bent geometries. 
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4.1.2 Displacement and Non-linear constant calculations 
In the u-shaped bioreactor, the three rectangular- shaped specimens was fixed on 
one end and permitted to move linearly with the use of an actuator (UltraMotion, 
Cutchogue, NY) from the other end. The actuator moved 0.5 inches forward in 0.5 
seconds and 0.5 inches back to the initial position in the next 0.5 seconds. Therefore, 
the duration of one full cycle is one second (frequency of 1Hz). A fortran code was 
written using the equations that govern the actuator displacement, and 250 displacement 
values were obtained at an interval of 2 milliseconds. These values represented the axial 
displacement of the actuator for half a cycle (0.5 seconds). Specimens were assumed to 
take a parabolic shape and fit to the arc equation, given by:  
׬ ඥ1 ൅ ሺܥݔሻଶ		మ௕ି଼.ହ ݀ݔ ൌ 17݉݉                                                                     Eq.1           
Where b is the new position of the moving end as it moved to the stationary end 
and C is the nonlinear parabolic constant. The shape conformed to the equation of an 
arc with the constraint of a fixed specimen axial length of 17 mm. In this way, the 
sample length was preserved at each axial displacement and the nonlinear constant is 
obtained. The constant, “C” was computed numerically in Mathcad™ (v.15, PTC, 
Needham, MA) over a total of 250 time steps.  
4.1.3 Tests for Independence 
Independence tests were performed on meshing, time step, and periodicity for 
steady and pulsatile simulations accordingly. As the monitored variable, the area 
averaged wall shear stress on the samples was used. A 5% error acceptance criterion in 
comparison with highly resolved simulations was employed.  
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4.1.4 Methodology for aim 1- Steady state simulations 
From the 250 spatial positions, efforts focused on building an initial mesh at t = 
0 (fully straight state) and 10 subsequent meshes equally spaced, such that the last mesh 
corresponded to the fully flexed state (t = 0.5 s). The time step between these meshes 
was 50 ms. In this manner a quasi-static analysis of the flow field across these 11 static 
meshes was conducted.  The boundary condition at the inlet was specified to be a plug 
velocity of 2.2 cm/s. Also, the outlet was set to an opening static pressure of 0 Pa.  
4.1.5 Methodology for aim 2- Static pulsatile simulations 
For the pulsatile simulations, a pulmonary artery flow rate waveform obtained 
from Lotz et. al. [60] was used. The waveform had a total duration of 1.2 seconds for 
one full cycle, and it was adjusted such that it has duration of one second. This was 
done because previous calculations for the axial displacements and non-linear constants 
used a 1-second cycle (Fig. 7a). Subsequently, the waveform was conversed to time 
(seconds) vs velocity (cm/s) (Fig. 7b) and used as the inlet velocity profile.  
 
(A) 
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(B) 
Figure 7. A) Flow rate waveform adjusted from 1.2 sec (original from lotz, et. at.[60] 
) to 1 sec.  B) Velocity waveform with a velocity average of 0.199386 cm/s.  
 
 Steady Pulsatile 
Flow Laminar Flow Laminar Flow 
Walls Walls-No slip conditions Walls-No slip conditions 
Inlet Plug velocity  
0.02 m/s 
Velocity waveform  
Outlet Outlet-Opening pressure 
= 0 Pa 
Outlet-Opening pressure 
= 0 Pa 
Convergence 5x10-5 5x10-5 
Table 1. Parameters for steady and pulsatile simulations. 
4.1.6 Oscillatory Shear Stress  
Oscillatory shear stresses were quantified by means of an oscillatory shear index (OSI), 
as described by He and Ku[61] . OSI can be obtained by using the following equations. 
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Where 
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0
τ  = The magnitude of the time averaged shear stress                             Eq.6 
In the quasi static analysis T dt
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=                                                                            Eq.8 
Where 
iSSx = x component of shear stress                                                               Eq.9 
iSSy = y component of shear stress                                                               Eq.10 
iSSz = z component of shear stress                                                               Eq.11 
i  = 1,2,3…11 represents the number of each of the eleven sample geometries where 1 
represents the number of each of the eleven sample geometries. 
i = 1,2,3…11 represents the number of each of the eleven sample geometries where 1 
represents the straight geometry and 11 represents the fully bent position. 
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For the pulsatile case T dt
0
τ and  T dtabs
0
)(τ  can be obtained by using equation Eq. 7 and 
Eq.8. In this case, 
i = 1,2,3…11 represents 11 waveform time points evenly spaced, where 1 represents time 
at t = 0 and 11 represents time at t = 1 second. 
4.2 Methodology for aim 3- Cell Culture experiments 
4.2.1 Cell Differentiation: BMSCs were cultured in T-75 flasks in a 37oC incubator until 
100% confluence was reached. The cells were split to obtain a cell density of 17x106 
cells/cm2 and cultured for an additional week. Group 1(n=4) contained BMSC cultured in 
a 96 well-plate under static flow. Group 2 (n=4) this group of BMSCs was cultured in the 
Bioflux 200 system (Fluxion Biosciences, San Francisco, CA) and exposed to steady 
flow with a shear stress of 1.5dyn/cm2. Group 3 (n=4) - contained BMSCs cultured in the 
Bioflux 200 system and exposed to a pulsatile shear stress obtained from a physiological 
pulmonary valve waveform [60].  
4.2.2 Culture Media: The media contained DMEM High glucose (Invitrogen, Carlsbald, 
CA), 10% fetal bovine serum (ATCC, Manasas, VA), 1% antibiotic/antimycotic, 1% 
HEPES (Invitrogen, Carlsbald, CA), 2ηg/mL of basic fibroblast growth factor (bFGF, 
Invitrogen, Carlsbald, CA), 82µg/mL Ascorbic Acid (Sigma-Aldrich, St. Louis, MO). 
The media was changed every 24 hours for a period of one week. The amount of media 
added to each well for the 24-microfluidic well plate, was 3ml, and for the 96-well plate 
(group 1) was 200µL. The 82µg/mL of Ascorbic acid was added to the media. 
4.2.3 Bioflux 200 System: The Bioflux 200 system consists of a pneumatic pump, a 24-
microfluidic well plate, a 24-well plate interface, and a user operated software.  The 
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system allows inputting the desired shear stress for both continuous and pulsatile flow. 
The Bioflux 200 is connected to a microscope with a CCD camera allowing the user to 
take photographs of the cultured cells under flow.  This system is efficient for stem cell 
applications, such as cell differentiation. 
4.2.4 Assays:  
Cell Differentiation-RNA Isolation and Reverse Transcription: SMCs were washed with 
PBS and removed from the T-75cm2 flask (Fisher Scientific, PA) by 0.25%Trypsin-
EDTA (ATCC, Manasas, VA). Then, the detached cells were gathered in a 15 ml conical 
tube (Fisher Scientific, PA). In order to perform the RNA isolation procedure, the cells 
were transferred to a 1.5 ml RNAase free tube. Total mRNA was purification of mRNA 
was performed through the SV Total RNA Isolation System (Promega, Madison, WI). 
Reverse transcription reaction was performed on 1µg of total mRNA with GoScript™ 
Reverse Transcription System (Promega, Madison, WI). Detection was performed by 
using a Step One Real-Time PCR System (Applied Biosystems, Carlsbad, CA). The 
cycling parameters were 950C, 5 seconds; 600C, 45 seconds; 950C, 15 seconds. 
4.2.5 Statistics 
Independent two sample t-test 
n
S
xxt
XX
2)(
21
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1 −
=                                                                                  Eq.12 
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1 22
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SS +                                                                       Eq.13 
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2
1X
S = variance of first group 
2
2X
S = variance of second group 
Degrees of freedom = 2n-2 
n = number of samples 
Assumptions: 
Equal variance 
5 RESULTS FOR AIM 1 AND AIM 2 
CFD simulations were run with the U-shaped tube geometry, housing three 
rectangular specimens that depicted a conditioning chamber of the bioreactor.  Solution 
convergence was achieved at the prescribed residual values for continuity and motion 
equations (<5.0 x 10-5). Uniformity in shear stresses between specimens (N =3 
specimens) housed within the bioreactor was observed and was found to be consistent 
with previous studies [8] inter-specimen variation of shear stresses was all found to be 
within 5% in all simulations performed. 
 As shown in Figure 8, there is higher variability of shear stress magnitude in the 
outer wall of the samples for both pulsatile and quasi-static scenarios. The outer walls 
show higher shear stress at the upstream region when compared to the downstream area. 
Average inner wall specimen shear stresses (N=3) were found to be 0.05 Pa (straight), 
0.09 Pa (semi-bent) and 0.1 Pa (fully-bent), whereas the time-averaged shear stress over 
11 specimen configurations was found to be 0.03 Pa (quasi-static) (Fig. 9). Average outer 
wall shear stresses were 0.05 Pa (straight-pulsatile), 0.12 Pa (semi-bent-pulsatile), 0.17 
Pa (fully-bent-pulsatile), and a time-average shear stress of 0.11 Pa was computed from 
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the quasi-static analysis (Fig. 9). In brief, the outer wall shear stress is higher when 
compared to the inner wall. This is due to higher momentum forces acting on the outer 
surface due to the moving flow that encounters it. 
 
Figure 8. Time averaged wall shear stress distributions in the inner (n=3) 
and outer (n=3) walls of the specimen for three geometry positions under pulsatile 
and quasi-static conditions. 
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Figure 9. Bar chart showing time averaged shear stress. 
 
 
The direction of the shear stress vectors at different instantaneous velocities in 
one full cycle was observed (Fig 10-16). Particularly, observations were performed at 
the higher velocity range in the waveform because there are more fluid environments 
alterations in this area. Specifically, three time intervals during the acceleration phase (t 
= 0.028 sec, vel= 2.9 cm/s; t = 0.05 sec, 2.9 cm/s; t = 0.1, sec 5.2 cm/s) were observed, 
maximum velocity (t = 0.13, sec 8.9cm/s), and three time intervals during the 
deceleration phase (t = 0.168 sec, 7.6 cm/s; t = 0.256 sec, 5.2 cm/s; t = 0.314, sec 2.9 
cm/s). It was observed that in the straight samples (Fig 6, 7) shear stress vectors travel in 
the same direction as the flow during the acceleration period. On the other hand, these 
vectors were found to be in the complete opposite direction to the flow during the 
deceleration phase. For the case of the semi-bent and fully bent cases, it was observed 
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that the wall shear vectors change direction even at the acceleration phase. This is 
particularly visible at the inner walls.  
 
 
Figure 10. Inner wall of a straight sample shear stress magnitude with 
superimposed wall shear vectors. 
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Figure 11. outer wall of a straight sample shear stress magnitude with superimposed 
wall shear vectors. 
 
Figure 12. Inner wall of a semibent sample shear stress magnitude with 
superimposed wall shear vectors. 
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Figure 13. Outer wall of a semibent sample shear stress magnitude with 
superimposed wall shear vectors. 
 
Figure 14. Inner wall of a fully-bent sample shear stress magnitude with 
superimposed wall shear vectors. 
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Figure 15. Outer wall of a fullybent sample shear stress magnitude with 
superimposed wall shear vectors. 
In order to observe the role that velocity acceleration and deceleration had on the 
direction of shear stress streamlines, an instantaneous velocity of 2.2 cm/s for both 
phases of acceleration was used. This is also the velocity that was used as the inlet 
condition for the steady state simulations. Specimen friction streamlines were found to 
be in the fully forward direction under steady flow and during the acceleration phase of 
the pulsatile flow waveform (Fig. 16). On the other hand, complete flow reversal was 
observed during the deceleration phase on both the inner and outer walls of the 
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specimens. 
 
 
Figure 16. Shear stress streamlines on the outer and inner walls of a straight 
sample under steady (vel=0.022m/s) and pulsatile conditions.  
 
Observations on the axial shear stress profiles for three sample configurations 
simulated under steady profiles was done (Fig. 17).  Shear stress vectors show the 
direction of the flow when the sample was in a straight configuration. Shear stress 
vectors did not follow the direction of the flow when the sample was semi or fully-bent. 
This observation can be seen more clearly in the inner walls of the samples.  
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Figure 17. Axial shear stress (Flow direction) streamlines on the outer and inner 
walls of a straight sample in steady state cases (vel=2.2cm/s). 
 
 Figures 18 and 19 show the axial shear stress at different instantaneous 
waveform velocities with straight sample positions. The vectors follow the direction of 
the flow in the inner wall. There was a slight change in the direction of the vectors at the 
last instantaneous velocity of the deceleration phase in the outer wall (Fig 19). Axial 
shear stress magnitude increased with increasing velocity (Fig 20, 21).  
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Figure 18. Inner wall of a straight sample  with superimposed axial (Flow-direction) 
shear stress vectors at steady and instantaneous velocities. 
 
 
Figure 19. Outer wall of a straight sample  with superimposed axial (Flow-direction) 
shear stress vectors at steady and instantaneous velocities. 
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Figure 20. Inner wall of a straight sample  showing axial shear stress magnitude at 
steady and instantaneous velocities. 
 
Figure 21. Outer wall of a straight sample  showing axial shear stress magnitude at 
steady and instantaneous velocities. 
 
 
33 
 
OSI variability was highest along the inner and outer walls (N=3 specimens) in 
the quasi static case (Fig.22). On the other hand, OSI variability was lowest along the 
inner and outer walls of straight samples (N=3) subjected to pulsatile flow. OSI 
distribution was highest along both the inner and outer walls when specimens (N=3) were 
held fixed in a straight configuration (average specimen OSI = 0.26, inner wall; average 
specimen OSI = 0.27, outer wall) and subjected to a physiologically-relevant pulsatile 
flow field (Fig.23).  From the quasi-static analysis, when the flow was steady, the OSI 
reduced by ~ 62% on the inner wall and ~ 8% on the outer wall.  Finally, when the 
specimen configuration was fixed in a bent-state, the OSI decreased in comparison to the 
straight specimens under pulsatile flow conditions (Fig.23). In addition, OSI was plotted 
along the centerline of one sample  (Fig. 24 & 25). 
 
Figure 22. Oscillatory shear index contour for the inner (n=3) and outer walls (n=3). 
It shows four cases: straight pulsatile, semi-bent pulsatile, fully-bent pulsatile 
and quasi-static.  
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Figure 23. Bar chart showing OSI. 
 
 
Figure 24. Inner wall OSI distribution along the centerline of samples. 
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Figure 25. Outer wall OSI distribution along the centerline of samples. 
 
 Observations for velocity in the steady cases were conducted by using a centerline 
through the upper chamber of the bioreactor as shown on figure 26a. Initial observations 
on the lower chamber did not show significant velocity changes. Regions of velocity 
absence was observed for the semi-bent and fully bent geometries. This was due to higher 
sample flexures that intersected and surpassed the centerline of the chamber (Fig. 26b). 
Interestingly, the velocity increased as it approached the sample location and it further 
augmented as it encountered the second and third sample. The velocity closer to the 
outlet was higher that the velocity at the start of the chamber. This suggests that the 
presence of the sample created a narrowing in the total cross sectional area of the 
chamber and it resulted in observed velocity intensification.  
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Figure 26. (a) Centerline showing the upper and lower chamber of the u-shaped 
bioreactor (b) Steady state velocity at the upper chamber centerline for three 
sample configurations. 
 
In order to have a better understanding of the velocity profile found in straight 
samples subjected to pulsatility, the velocity at the center line of the upper chamber (Fig. 
26a) at specific time intervals was plotted. Specifically, these observations were done at 
0.1 sec (Fig. 27), 0.13 sec (Fig. 28),  0.15 sec (Fig. 29),  and 0.2 sec (Fig. 30). The time t 
(a) 
(b) 
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= 0.13 sec, corresponds to the highest velocity value (8.9cm/s) from the waveform and 
shows higher velocity magnitudes over the other time points (Fig. 28). Interestingly,   the 
velocity at the x = 0 m (beginning of the chamber) are remarkably similar to the velocity 
close to the outlet. In addition, there is an increase in velocity in the proximity of the 
samples, but it decreases as it passes away from them. Furthermore, these velocity 
increments are remarkably similar among the centerline regions in proximity with the 
samples.  
 
 Figure 27. Velocity along the centerline at t = 0.1 sec (straight samples).  
 
 
Figure 28. Velocity along the centerline at t = 0.13 sec (straight samples).  
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Figure 29. Velocity along the centerline at t = 0.15 sec (straight samples).  
 
 
Figure 30. Velocity along the centerline at t = 0.2 sec (straight samples).  
 
Time averaged vorticity magnitudes along the centerline of the upper chamber 
were plotted (Fig. 31). Regions of vorticity absence was observed for the semi-bent and 
fully bent geometries. This was due to higher sample flexures that intersected and 
surpassed the centerline of the chamber. Similarly, this may have  played a role in the 
quasi-static vorticity quantification due to highly flex samples.  Figure 31 reveals areas of 
very high vorticity magnitude in regions of close proximity to the upstream side of the 
samples. In the case of the straight configuration, vorticity centerline profiles showed 
remarkable similarity among samples. Because of this it was decided that a closer look at 
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the centerline vorticity of straight samples needed to be performed. The instantaneous 
vorticity at t = 0.13 sec corresponding to the highest velocity point (8.9cm/s) was 
designed (Fig. 32).  
 
Figure 31. Time average vorticity along the centerline of the upper chamber  for 
pulsatile and quasi-static.  
 
 
Figure 32. Instantaneous vorticity along the centerline of the upper chamber  with 
straight samples and pulsatile flow.  
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5.1 Discussion 
In cardiovascular tissue engineering, there is widespread agreement that dynamic 
culture using mechanical conditioning protocols, promotes tissue formation. It is been 
shown that in-vitro conditioning by means of flow environments enhances engineered 
tissue formation [1,7,8] and regulate  specific transcription factors of progenitor cells that 
modulate phenotype [16,54].  However, the explicit flow criteria for supporting tissue 
growth, in the context of HVTE efforts have not been sufficiently identified. Thus, there 
is ambiguity on the precise fluid-induced mechanisms governing the production of de 
novo valve tissue [7,8,45].  Some observations suggest that it is the oscillatory stress 
environments that are responsible for stimulating tissue development [7,38]. 
This study investigated and quantified the role that i) specimen configuration and 
ii) use of a physiologically relevant pulsatile flow waveform have on creating OSS 
environments. It was found that   physiologic OSS environments are maximized when 
specimens were placed in a fixed, straight configuration and were exposed to a pulsatile 
waveform [60]. Moreover, this setting comes accompanied with a highly uniform OSS 
distribution across all samples housed within the bioreactor thereby ensuring minimal 
variation in engineered tissue formation between specimens. 
 These findings demonstrate that OSS focused experiments for HVTE does not 
require a moving component and simplifies the design of a bioreactor for supporting 
these investigations. However the flow source has to be able to incorporate physiological 
waveforms and induce pulsatile flow through the conditioning chamber.  This can be 
readily accomplished using a peristaltic pump [8]. [38] reported higher tissue formation 
under conditions of flow and flexure combined. The quasi-static results suggest that this 
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could be partially due to the OSS environments caused by cyclic alteration in the fluid 
environments due to the deforming sample submerged into the continuous flow. 
Engelmayer et al. (2006) [16] reported an increase in number of cells and tissue 
formation in constructs conditioned by means of pulsatile flow over controls (no flow). 
The pulsatile simulations over static scaffolds subjected to pulsatile flow regimes 
suggest that OSS might have played a role in these findings by promoting cell 
proliferation and tissue formation. Support for this belief can be found in bone tissue 
engineering studies [53,62]. It should be noted that a limitation of this study was that it 
did not account for fully dynamic states; rather it took a quasi-static approach in 
considering OSS environments resulting from changing specimen configurations.  A true 
dynamic CFD simulation would require incorporation of fluid-structure or other moving 
boundary approaches which would require more computational implementation and time, 
yet unnecessary for the purposes of a primary objective here, which was to reasonably 
approximate the OSS distributions on the specimens.  This was achieved by the quasi-
static model, firstly by the use of meshes that accurately depicted varying specimen 
geometry at snapshot temporal positions.  Secondly, the model operated in the laminar 
range and was prescribed a uniform inlet velocity condition, which would enable any 
given fluid particle in the conditioning chamber to come into regular, periodic contact 
with a housed specimen undergoing cyclical flexure, thus having roughly the same shape 
at that time instant.  
Another limitation is that it only considered the singular effect of OSS on tissue 
formation which is thought to be beneficial [7,8,63].  It is however important to note that 
specimen movement may provide added benefits to tissue formation, by enhancing mass 
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transport of nutrients to the growing tissues.   Efforts are currently investigating the role 
of valve-like specimen movement on engineered tissue formation by BMSCs in 
bioreactor-based experiments that are being conducted in our laboratory. In summary, 
this report has shown that OSS can be maximized by inducing pulsatile flow over straight 
scaffolds. There is strong evidence to believe that OSS promotes BMSCs tissue 
formation. 
6 RESULTS AND DISCUSSION FOR AIM 3  
 HVTE studies have shown that pulsatile environments can promote cell 
proliferation and tissue formation. This study has shown, through CFD analysis, that 
during pulsatility there are high areas of OSS acting on the surface of rectangular 
specimens. In addition, these environments can be maximized by conforming to a straight 
sample configuration. As a next step, efforts to performed in-vitro studies of BMSCs 
cultured under no flow and steady flow regimens are underway.  
Initially, ΔCt values were averaged and were subsequently normalized with GAPDH. 
Statistical t-tests were performed over the 2-ΔCt values for comparison among no flow 
and steady flow groups. The results showed an increase in the number of cells attached to 
the walls of the micro channel with increasing culture time (Fig. 33). The effect of flow 
compared to no flow on BMSCs was significantly different (P < 0.05). Specifically, 
significant differences were observed on B-1-INT, PECAM-1, and VECADHERIN (Fig. 
34). B-1-INT is associated with extracellular matrix formation (i.e Collagen) [1]. 
PECAM-1 is an adhesion molecule expressed by vascular ECs [46]. VECADHERIN is 
important in supporting the EC phenotype and has a critical role in vascular development 
[58]. 
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Figure 33. Bar chart showing the number of cells per day during the steady flow 
experiment. 
 
Figure 34. Bar chart showing the genes expressed after no flow and steady flow 
conditions. 
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Pulsatile in-vitro experiments are currently in progress and will provide with quantitative 
data to assertively delineate any cell proliferation and phenotypic differences between 
steady and pulsatile flow conditions. In addition, in subsequent in-vitro experiments, 
evaluation of tissue formation will be performed. Nonetheless, it can be concluded that 
steady flow alone promotes cell proliferation and phenotypic differentiation. 
 The quasi-static results showed that OSS environments can be caused by means of 
cyclic sample flexure. Previous in-vitro experimental data obtained from samples 
cultured under cyclic flexure combined with flow conditions show higher tissue 
formation over controls of flow or cyclic flexure alone (Fig. 35). In addition, flex and 
flow combined groups showed higher elastic modulus than the other groups. 
 
Figure 35. Collagen assay results for BMSC-seeded 50:50 PGA/PLLA scaffolds [38]. 
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Similarly, Ramaswamy et al. [7] reported increase in tissue formation in scaffolds 
seeded with BMSCs and conditioned by means of dynamic sample movement. They used 
a native valve-like (organ level) geometries and rectangular scaffolds (FSF-level). The 
organ level constructs subjected to dynamic conditioning had highest collagen production 
followed by the dynamic regimen of rectangular samples (Fig. 35).  
 
 
Figure 36. A compilation of the temporal evolution of collagen mass production for 
all groups investigated at the tissue and organ levels [7]. 
 
7 CONCLUSION 
Through a computational modeling approach this study has shown that OSS can 
be maximized by inducing pulsatile flow over straight scaffolds. Specifically, these 
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results have shown that in average OSS environments show higher magnitude and that 
there it is more homogeneously distributed along the sample walls.  These findings 
demonstrate that experiments for HVTE that focus on OSS do not require a moving 
component. In this way, bioreactor designs could be further simplified to accommodate 
for pulsatility rather than movement by means of external actuators. It is our belief that 
OSS promotes BMSCs proliferation and tissue formation. The results of this study have 
shown that there is strong evidence to support this hypothesis. Current efforts are focused 
on in-vitro experiments that will provide with quantifiable data.   
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